- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
MRX Market Currents
more »
-
May 8 Medicis Pharmaceutical (MRX): Q1 EPS of $0.60 beats by $0.18. Revenue of $202M (+22% Y/Y) beats by $17M. Shares -0.4% AH. (PR)
Comment![Earnings, Healthcare]
MRX Related Articles
more »
MRX News
more »
-
at MarketWatch.com (Feb 27, 2012)
-
at CNBC.com (Dec 28, 2011)
-
at MarketWatch.com (Dec 28, 2011)
-
at MarketWatch.com (Dec 28, 2011)
-
at MarketWatch.com (Dec 27, 2011)
MRX Press Releases and Filings
more »
-
GlobeNewswire (May 14, 2012)
-
GlobeNewswire (May 11, 2012)
-
GlobeNewswire (May 10, 2012)
-
GlobeNewswire (May 8, 2012)
-
GlobeNewswire (May 3, 2012)
MRX Latest Transcript
more »
MRX Cramer
more »
-
Fri, Aug 20, 2010
-
Thu, Aug 5, 2010
-
Tue, Mar 16, 2010
MRX Instablog posts
more »
MRX vs. ETF Alternatives
Company Description
Medicis Pharmaceutical Corporation together with our wholly owned subsidiaries, is a leading independent specialty pharmaceutical company focusing primarily on helping patients attain a healthy and youthful appearance and self-image through the development and marketing in the United States... More